Hemostatic factors, innate immunity and malignancy (Q84340525)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682116%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

title

Hemostatic factors, innate immunity and malignancy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682116%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Jay L Degen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682116%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Joseph S Palumbo

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682116%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

1 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682116%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682116%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

129 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682116%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

S1-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682116%20AND%20SRC:MED&resulttype=core&format=json

Trousseau's syndrome: multiple definitions and multiple mechanisms

4 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Treatment of thromboembolism in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Genetic link between cancer and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Venous thromboembolism and prognosis in cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Role of tissue factor in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

The role of tissue factor in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Clinical significance of the ratio between the alpha 2 plasmin inhibitor-plasmin complex and the thrombin-antithrombin complex in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Antitumor and antimetastatic effect of warfarin and heparins.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Tissue factor and cancer stem cells: is there a linkage?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Mechanisms linking tumor cell-associated procoagulant function to tumor dissemination

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Tissue factor and protease-activated receptor signaling in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Tissue factor and PAR2 signaling in the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Tissue factor and cell signalling in cancer progression and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Effect of tissue factor deficiency on mouse and tumor development

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Contribution of host-derived tissue factor to tumor neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Platelets: linking hemostasis and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Modulation of natural killer cell anti-tumor reactivity by platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Anticoagulants and cancer survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Thrombosis in cancer: an update on prevention, treatment, and survival benefits of anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Regulation of inflammation by the protein C system

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Role of activated protein C and its receptor in inhibition of tumor metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Endogenous activated protein C limits cancer cell extravasation through sphingosine-1-phosphate receptor 1-mediated vascular endothelial barrier enhancement

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

The cytoprotective protein C pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Inflammation and coagulation in inflammatory bowel disease: The clot thickens

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

The development of inflammatory joint disease is attenuated in mice expressing the anticoagulant prothrombin mutant W215A/E217A.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Fibrin(ogen)-alpha M beta 2 interactions regulate leukocyte function and innate immunity in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Amelioration of collagen-induced arthritis by thrombin inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Reduced thrombin generation increases host susceptibility to group A streptococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Cancer-related inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Inflammation and colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Colitis-associated cancer is dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin alpha(M)beta(2) engagement of fibrinogen

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

The interactions between inflammation and coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

Coagulation and innate immune responses: can we view them separately?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

The interface between coagulation and immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

The many faces of tissue factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970143-3

7 January 2021

10.1016/S0049-3848(12)70143-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682116%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference